Xaracoll® (bupivacaine) – New drug approval
August 31, 2020 - Innocoll announced the FDA approval of Xaracoll (bupivacaine), in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.
Download PDF
